2019 annual financial data

Redhill Biopharma 2019 Financial results

Direct answer

Revenue was 6,291,000 USD.

Operating income was -43,201,000 USD and net income was -42,304,000 USD.
Operating cash flow was -40,749,000 USD.

Get free Redhill Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
6,291,000 USD
Operating income
-43,201,000 USD
Net income
-42,304,000 USD
Operating cash flow
-40,749,000 USD